{"entity":{"type":"insider","cik":"0001327897","url":"/insider/0001327897","json_url":"/insider/0001327897.json","name":"Mendelson Daniel Newman","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":31,"first":"2014-03-21","last":"2024-01-16","span_basis":"filed_date"},"name_variants":[{"name":"Mendelson Daniel Newman","source":"filing","n_filings":31,"first_seen":"2014-03-21","last_seen":"2024-01-16"}],"transactions":[{"id":2647264,"accession":"0001628280-24-001334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-001334","line_url":"/filing/0001628280-24-001334#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":6500.0,"total_display":"6,500.00","total_whole":"6,500","shares_owned_after":198625.0,"shares_owned_after_display":"198,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-12","filed_date":"2024-01-16","scope":"insider"},{"id":2489488,"accession":"0001628280-24-001231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-001231","line_url":"/filing/0001628280-24-001231#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.27,"price_display":"6.27","price_state":"stated","total_value":12540.0,"total_display":"12,540.00","total_whole":"12,540","shares_owned_after":197625.0,"shares_owned_after_display":"197,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-12","scope":"insider"},{"id":2522263,"accession":"0001628280-24-001118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-001118","line_url":"/filing/0001628280-24-001118#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2944.0,"shares_display":"2,944","price_per_share":6.31,"price_display":"6.31","price_state":"stated","total_value":18576.64,"total_display":"18,576.64","total_whole":"18,577","shares_owned_after":195625.0,"shares_owned_after_display":"195,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-11","scope":"insider"},{"id":2063728,"accession":"0001628280-24-001002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-001002","line_url":"/filing/0001628280-24-001002#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":18750.0,"total_display":"18,750.00","total_whole":"18,750","shares_owned_after":192681.0,"shares_owned_after_display":"192,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-10","scope":"insider"},{"id":2732254,"accession":"0001628280-24-000896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-000896","line_url":"/filing/0001628280-24-000896#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.15,"price_display":"6.15","price_state":"stated","total_value":6150.0,"total_display":"6,150.00","total_whole":"6,150","shares_owned_after":189681.0,"shares_owned_after_display":"189,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":3261227,"accession":"0001628280-24-000825","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-000825","line_url":"/filing/0001628280-24-000825#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":12180.0,"total_display":"12,180.00","total_whole":"12,180","shares_owned_after":188681.0,"shares_owned_after_display":"188,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-08","scope":"insider"},{"id":3135365,"accession":"0001628280-24-000820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-000820","line_url":"/filing/0001628280-24-000820#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":6.12,"price_display":"6.12","price_state":"stated","total_value":18360.0,"total_display":"18,360.00","total_whole":"18,360","shares_owned_after":186681.0,"shares_owned_after_display":"186,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-08","scope":"insider"},{"id":2291131,"accession":"0001628280-24-000388","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-000388","line_url":"/filing/0001628280-24-000388#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":2915.0,"total_display":"2,915.00","total_whole":"2,915","shares_owned_after":183681.0,"shares_owned_after_display":"183,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider"},{"id":8716100,"accession":"0001628280-23-042662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-042662","line_url":"/filing/0001628280-23-042662#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":4.92,"price_display":"4.92","price_state":"stated","total_value":12300.0,"total_display":"12,300.00","total_whole":"12,300","shares_owned_after":183181.0,"shares_owned_after_display":"183,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-26","scope":"insider"},{"id":8593606,"accession":"0001628280-23-042467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-042467","line_url":"/filing/0001628280-23-042467#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":4.82,"price_display":"4.82","price_state":"stated","total_value":10122.0,"total_display":"10,122.00","total_whole":"10,122","shares_owned_after":180681.0,"shares_owned_after_display":"180,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-21","scope":"insider"},{"id":7881715,"accession":"0001628280-23-042096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-042096","line_url":"/filing/0001628280-23-042096#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":23750.0,"total_display":"23,750.00","total_whole":"23,750","shares_owned_after":178581.0,"shares_owned_after_display":"178,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-20","scope":"insider"},{"id":8047621,"accession":"0001628280-23-034348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-034348","line_url":"/filing/0001628280-23-034348#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.4,"price_display":"6.40","price_state":"stated","total_value":32000.0,"total_display":"32,000.00","total_whole":"32,000","shares_owned_after":163081.0,"shares_owned_after_display":"163,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-11","filed_date":"2023-10-13","scope":"insider"},{"id":7983277,"accession":"0001628280-23-034231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-034231","line_url":"/filing/0001628280-23-034231#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":6.41,"price_display":"6.41","price_state":"stated","total_value":7051.0,"total_display":"7,051.00","total_whole":"7,051","shares_owned_after":158081.0,"shares_owned_after_display":"158,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-10","filed_date":"2023-10-11","scope":"insider"},{"id":8408830,"accession":"0001628280-23-034119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-034119","line_url":"/filing/0001628280-23-034119#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1530.0,"shares_display":"1,530","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":9914.4,"total_display":"9,914.40","total_whole":"9,914","shares_owned_after":156981.0,"shares_owned_after_display":"156,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-06","filed_date":"2023-10-10","scope":"insider"},{"id":8564107,"accession":"0001628280-23-034004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-034004","line_url":"/filing/0001628280-23-034004#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.47,"price_display":"6.47","price_state":"stated","total_value":12940.0,"total_display":"12,940.00","total_whole":"12,940","shares_owned_after":155451.0,"shares_owned_after_display":"155,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-05","filed_date":"2023-10-06","scope":"insider"},{"id":8639830,"accession":"0001628280-23-033842","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-033842","line_url":"/filing/0001628280-23-033842#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.4,"price_display":"6.40","price_state":"stated","total_value":32000.0,"total_display":"32,000.00","total_whole":"32,000","shares_owned_after":153451.0,"shares_owned_after_display":"153,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-04","scope":"insider"},{"id":8690434,"accession":"0001628280-23-033843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-033843","line_url":"/filing/0001628280-23-033843#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":6.3,"price_display":"6.30","price_state":"stated","total_value":15750.0,"total_display":"15,750.00","total_whole":"15,750","shares_owned_after":148451.0,"shares_owned_after_display":"148,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-04","scope":"insider"},{"id":8238477,"accession":"0001628280-23-034409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-034409","line_url":"/filing/0001628280-23-034409#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":6.16,"price_display":"6.16","price_state":"stated","total_value":24640.0,"total_display":"24,640.00","total_whole":"24,640","shares_owned_after":173581.0,"shares_owned_after_display":"173,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-29","filed_date":"2023-10-16","scope":"insider"},{"id":8129640,"accession":"0001628280-23-034407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-034407","line_url":"/filing/0001628280-23-034407#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.22,"price_display":"6.22","price_state":"stated","total_value":31100.0,"total_display":"31,100.00","total_whole":"31,100","shares_owned_after":169581.0,"shares_owned_after_display":"169,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-10-16","scope":"insider"},{"id":8661596,"accession":"0001628280-23-034405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-034405","line_url":"/filing/0001628280-23-034405#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":8925.0,"total_display":"8,925.00","total_whole":"8,925","shares_owned_after":164581.0,"shares_owned_after_display":"164,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-10-16","scope":"insider"},{"id":8661554,"accession":"0001628280-23-033077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-033077","line_url":"/filing/0001628280-23-033077#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.65,"price_display":"5.65","price_state":"stated","total_value":28250.0,"total_display":"28,250.00","total_whole":"28,250","shares_owned_after":145951.0,"shares_owned_after_display":"145,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-26","filed_date":"2023-09-27","scope":"insider"},{"id":7881510,"accession":"0001628280-23-032917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-032917","line_url":"/filing/0001628280-23-032917#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3812.0,"shares_display":"3,812","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":20966.0,"total_display":"20,966.00","total_whole":"20,966","shares_owned_after":140951.0,"shares_owned_after_display":"140,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-25","scope":"insider"},{"id":7850817,"accession":"0001628280-23-032918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-032918","line_url":"/filing/0001628280-23-032918#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.51,"price_display":"5.51","price_state":"stated","total_value":27550.0,"total_display":"27,550.00","total_whole":"27,550","shares_owned_after":137139.0,"shares_owned_after_display":"137,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-21","filed_date":"2023-09-25","scope":"insider"},{"id":8025476,"accession":"0001628280-23-032919","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-032919","line_url":"/filing/0001628280-23-032919#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4018.0,"shares_display":"4,018","price_per_share":5.51,"price_display":"5.51","price_state":"stated","total_value":22139.18,"total_display":"22,139.18","total_whole":"22,139","shares_owned_after":132139.0,"shares_owned_after_display":"132,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-20","filed_date":"2023-09-25","scope":"insider"},{"id":8487802,"accession":"0001628280-23-032920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-032920","line_url":"/filing/0001628280-23-032920#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":26400.0,"total_display":"26,400.00","total_whole":"26,400","shares_owned_after":128121.0,"shares_owned_after_display":"128,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-25","scope":"insider"},{"id":2350633,"accession":"0001628280-20-004374","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-20-004374","line_url":"/filing/0001628280-20-004374","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1220.0,"shares_display":"1,220","price_per_share":5.912295081967213,"price_display":"5.91","price_state":"stated","total_value":7213.0,"total_display":"7,213.00","total_whole":"7,213","shares_owned_after":58446.0,"shares_owned_after_display":"58,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-26","filed_date":"2020-03-30","scope":"insider","n_lines":5},{"id":3163196,"accession":"0001628280-20-004087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-004087","line_url":"/filing/0001628280-20-004087#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26.0,"shares_display":"26","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":143.0,"total_display":"143.00","total_whole":"143","shares_owned_after":57526.0,"shares_owned_after_display":"57,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-24","filed_date":"2020-03-26","scope":"insider"},{"id":6367681,"accession":"0001628280-18-014013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-18-014013","line_url":"/filing/0001628280-18-014013#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.75,"price_display":"13.75","price_state":"stated","total_value":68750.0,"total_display":"68,750.00","total_whole":"68,750","shares_owned_after":57500.0,"shares_owned_after_display":"57,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-06","filed_date":"2018-11-08","scope":"insider"},{"id":6104497,"accession":"0001628280-18-012338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-18-012338","line_url":"/filing/0001628280-18-012338#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8333.0,"shares_display":"8,333","price_per_share":13.02,"price_display":"13.02","price_state":"stated","total_value":108495.66,"total_display":"108,495.66","total_whole":"108,496","shares_owned_after":62500.0,"shares_owned_after_display":"62,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-20","filed_date":"2018-10-05","scope":"insider"},{"id":8843050,"accession":"0001144204-15-016734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-016734","line_url":"/filing/0001144204-15-016734#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":750000.0,"shares_owned_after_display":"750,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-17","scope":"insider"},{"id":6530349,"accession":"0001144204-14-017171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-017171","line_url":"/filing/0001144204-14-017171#line-2","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":97500.0,"shares_display":"97,500","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":105300.0,"total_display":"105,300.00","total_whole":"105,300","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2014-03-21","scope":"insider"},{"id":6530345,"accession":"0001144204-14-017171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-017171","line_url":"/filing/0001144204-14-017171#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001327897","owner_name":"Mendelson Daniel Newman","owner_display_name":"Mendelson Daniel Newman","owner_url":"/insider/0001327897","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.048,"price_display":"1.05","price_state":"stated","total_value":2620.0,"total_display":"2,620.00","total_whole":"2,620","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-19","filed_date":"2014-03-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":34,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000771856","name":"CHAMPIONS ONCOLOGY, INC.","url":"/issuer/0000771856","role":"Director","n_filings":31,"first_seen":"2014-03-21","last_seen":"2024-01-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001327897","retrieved_at":"2026-08-26T20:41:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}